Antonio Giordano, MD, PhD. explains what COVID is and how to contain the infection, pointing also to what will require attention next. Please see this special release at http://online.fliphtml5.com/qlnw/zgau/#p=1
Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA
The article in Forbes discusses how the USA can learn from Italy, and their antibody testing during the Italy re-opening phase. There are many companies, international and local, which are racing to win the largest share of the COVID-19 antibody testing market in Italy. WHO warns that antibody tests may not be of great value, … Continue reading Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA
CORONAVIRUS EMERGENCY IN SICILY
A GoFundMe page has been set up to help Sicily during this crisis. Money raised will be used to help local organization in Palermo http://www.anirbas.org which assists the homeless by providing masks, food and other sanitary necessities especially in these times also dealing with Coronavirus emergency which especially affects the homeless and unemployed. Help us … Continue reading CORONAVIRUS EMERGENCY IN SICILY
Coronavirus, Antonio Giordano: “There is no connection with climate change”
The director of the Sbarro Institute in Philadelphia explains what COVID-19 is and how to contain the infection but underlines: "Pollution is a worse threat to our health" n the last few days we have witnessed panic scenes due to the spread of the coronavirus: escapes from the red zone, supermarkets taken by storm to stock … Continue reading Coronavirus, Antonio Giordano: “There is no connection with climate change”
Understanding COVID-19 Origins First Step to Treating Cases, Stopping Spread
“The new virus originating from Wuhan is the third coronavirus that has made the ‘jump’ from animals to humans,” explains Enrico Bucci, Ph.D., professor and research scientist at the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia. “We witnessed SARS, which infected 8,000 people between 2002 and 2003 and killed 775; and then … Continue reading Understanding COVID-19 Origins First Step to Treating Cases, Stopping Spread
Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert
Founder and Director of the Sbarro Health Research Organization (SHRO), Antonio Giordano, M.D., Ph.D., is uniquely qualified to comment on the current COVID-19 outbreak caused by the novel coronavirus known as SARS-CoV-2. A former physician turned research scientist, Giordano collaborates with scientists working in both the United States and Italy through projects with SHRO, Temple … Continue reading Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert
Link Found Between Bladder Cancer and Collagen Receptor, Revealing Possible Treatment Target
A team of investigators has recently discovered that the collagen receptor DDR1 functionally interacts with the insulin-like growth factor system in regulating bladder cancer. The study entitled “Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer” has been recently accepted in the international-peer-reviewed journal Matrix Biology Plus. This work is an international … Continue reading Link Found Between Bladder Cancer and Collagen Receptor, Revealing Possible Treatment Target
Researchers Find Potential New Target for Mesothelioma Treatment
by Tim Povtak Research & Clinical Trials Jan 14, 2020 An international research team has identified a novel molecular target with potential to significantly improve future treatment of malignant pleural mesothelioma. The recent findings could lead to a drug that targets key genetic inhibitors often preventing a patient’s own immune system from suppressing mesothelioma … Continue reading Researchers Find Potential New Target for Mesothelioma Treatment
Lower Survival in Patients with High BMI and HER2+ Metastatic Breast Cancer Treated with Pertuzumab and Trastuzumab
High BMI correlates to lower survival in patients with HER2+ metastatic breast cancer, even among patients showing initial positive response to new anti-HER2 agents pertuzumab and trastuzumab. An international team of researchers found that high BMI correlates to lower survival in patients with HER2+ metastatic breast cancer, even among patients showing initial positive response to … Continue reading Lower Survival in Patients with High BMI and HER2+ Metastatic Breast Cancer Treated with Pertuzumab and Trastuzumab
Virtual reality during chemotherapy could help improve breast cancer patients’ quality of life
Virtual Reality during chemotherapy has been shown to improve breast cancer patients' quality of life during the most stressful treatments, according to a recent study. Breast cancer is, to date, the most frequent oncological disease worldwide, and has an impact both from a physical and psychological point of view. Receiving a breast cancer diagnosis is … Continue reading Virtual reality during chemotherapy could help improve breast cancer patients’ quality of life
